Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Sky One Reports 140 Percent Increase In Revenue, Lists on American Stock Exchange

This article was originally published in PharmAsia News

Executive Summary

BEIJING - China Sky One Medical reported first quarter revenue of $12.4 million, marking a 140 percent increase year on year, the company told a May 15 earnings call

You may also be interested in...



China Sky One Starts Shift From OTC To Prescription Market

SHANGHAI - China Sky One Medical entered 11 new drugs enter into clinical trials, seven of which are injectable drugs, the company announced June 10, which could lead to the company's first foray into the injectable drug market in China

China Sky One Starts Shift From OTC To Prescription Market

SHANGHAI - China Sky One Medical entered 11 new drugs enter into clinical trials, seven of which are injectable drugs, the company announced June 10, which could lead to the company's first foray into the injectable drug market in China

China Sky One Receives Production Approval For Five Patches

SHANGHAI - China Sky One Medical has received production approvals for five new patches, including an anti-smoking patch, the company announced June 3

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel